ES1060042Y - Dispositivo de suministro de medicamentos - Google Patents

Dispositivo de suministro de medicamentos

Info

Publication number
ES1060042Y
ES1060042Y ES200402091U ES200402091U ES1060042Y ES 1060042 Y ES1060042 Y ES 1060042Y ES 200402091 U ES200402091 U ES 200402091U ES 200402091 U ES200402091 U ES 200402091U ES 1060042 Y ES1060042 Y ES 1060042Y
Authority
ES
Spain
Prior art keywords
delivery system
vaginal cavity
supply device
internal phase
high internal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200402091U
Other languages
English (en)
Other versions
ES1060042U (es
Inventor
Robert C Cuca
Thomas C Riley
R Saul Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of ES1060042U publication Critical patent/ES1060042U/es
Application granted granted Critical
Publication of ES1060042Y publication Critical patent/ES1060042Y/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B2017/4216—Operations on uterus, e.g. endometrium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
ES200402091U 2004-07-08 2004-09-09 Dispositivo de suministro de medicamentos Expired - Fee Related ES1060042Y (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58627304P 2004-07-08 2004-07-08
WOPCT/US04/22058 2004-07-08
PCT/US2004/022058 WO2006016869A1 (en) 2004-07-08 2004-07-08 Delivery system

Publications (2)

Publication Number Publication Date
ES1060042U ES1060042U (es) 2005-07-16
ES1060042Y true ES1060042Y (es) 2005-11-01

Family

ID=35787422

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200402091U Expired - Fee Related ES1060042Y (es) 2004-07-08 2004-09-09 Dispositivo de suministro de medicamentos

Country Status (13)

Country Link
EP (1) EP1765452A4 (es)
CN (2) CN1771023A (es)
AU (2) AU2004100776A4 (es)
BR (1) BRPI0513066A (es)
CA (1) CA2572919A1 (es)
CZ (1) CZ15068U1 (es)
ES (1) ES1060042Y (es)
FR (1) FR2872702B3 (es)
MX (2) MXPA04007681A (es)
NL (1) NL1026978C1 (es)
NZ (1) NZ552406A (es)
RU (1) RU2379027C2 (es)
WO (2) WO2006016869A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008651A1 (en) * 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
EP2100632A1 (en) 2008-03-11 2009-09-16 Pantarhei Devices B.V. Applicator device for body cavity
US8308678B2 (en) 2008-09-23 2012-11-13 Mcneil-Ppc, Inc. Pre-filled applicator device
EP2359750A1 (en) 2010-02-15 2011-08-24 Delphi Bioscience B.V. Screening device with valve
FR2968004B1 (fr) 2010-11-29 2013-06-28 Sojasun Technologies Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
RU2538703C2 (ru) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения вагинального кандидоза и способ ее получения
CN108525111A (zh) * 2015-09-18 2018-09-14 赵坚 一种妇科药防脱落的给药装置
CN112423826A (zh) * 2018-06-11 2021-02-26 宝洁公司 用于治疗阴道病症的方法和施用装置
CN109568130B (zh) * 2018-12-11 2021-02-05 管云 助力式配药器

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
US4636202A (en) * 1984-07-27 1987-01-13 Syntex (U.S.A.) Inc. Medicament applicator with plunger assembly and automatically-openable closure therefor
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
ES2133090B1 (es) * 1997-02-21 2000-04-01 Uriach & Cia Sa J Nuevo aplicador para la administracion de medicaciones semisolidas.
US6403576B1 (en) * 1998-08-24 2002-06-11 The United States Of America As Represented By The Secretary Of The Navy Antifungal and antiparasitic compounds
US20040047910A1 (en) * 2000-07-07 2004-03-11 Christian Beckett Suppository and composition comprising at least one polyethylene glycol
RU2207870C2 (ru) * 2000-11-10 2003-07-10 Панацея Биотек Лимитед Фармацевтическая композиция, включающая циклоспорин в качестве активного ингредиента

Also Published As

Publication number Publication date
MX2007000109A (es) 2007-03-26
CN1771023A (zh) 2006-05-10
EP1765452A4 (en) 2012-11-28
CZ15068U1 (cs) 2005-01-31
AU2005269844A1 (en) 2006-02-09
RU2007104782A (ru) 2008-08-20
WO2006014572A1 (en) 2006-02-09
NZ552406A (en) 2010-07-30
EP1765452A1 (en) 2007-03-28
CN102188375A (zh) 2011-09-21
BRPI0513066A (pt) 2008-04-22
WO2006016869A1 (en) 2006-02-16
NL1026978C1 (nl) 2006-01-10
RU2379027C2 (ru) 2010-01-20
AU2004100776A4 (en) 2004-11-18
MXPA04007681A (es) 2006-01-12
FR2872702B3 (fr) 2006-06-02
CA2572919A1 (en) 2006-02-09
ES1060042U (es) 2005-07-16
FR2872702A3 (fr) 2006-01-13

Similar Documents

Publication Publication Date Title
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
BRPI0418029B8 (pt) formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40
BR0306501A (pt) Método para uso e produção de um tampão com medicamento
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
BR0316157A (pt) Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
BR0014929A (pt) Dispositivo para distribuição de medicamento, e, processo para distribuir um agente farmaceuticamente ativo para um tecido alvo dentro de um corpo
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
NO20026171L (no) Topiske farmasöytiske formuleringer og fremgangsmåter for behandling
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
WO2007098479A3 (en) Localized insulin delivery for bone healing
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
BR112019006228A2 (pt) tratamento de câncer de próstata
FR2872702B3 (fr) Systeme de delivrance
CR7049A (es) Empleo de flumazenilo en la elaboracion de una medicacion para el tratamiento de la dependencia del alcohol
ATE458748T1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
AR048342A1 (es) FORMAS DE DOSIFICACIoN FARMACÉUTICAS QUE COMPRENDEN EL ÁCIDO N-(2-(2-FTALIMIDOETOXI)-ACETIL)-L-ALANIL-D-GLUTÁMICO (LK-423)
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
MY142098A (en) Delivery system
BR112021025291A2 (pt) Dispositivos de contenção de medicamento e composições associadas
BRPI0607172A2 (pt) método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos
MX387263B (es) Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma.
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
HK1244231A1 (zh) 使用hcg治疗慢性疼痛的方法和治疗

Legal Events

Date Code Title Description
FG1K Utility model granted
FD1K Utility model lapsed

Effective date: 20150826